|
POP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95950000669853E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.60329999779429E-08 |
| Normal-vs-Stage2 |
3.562100E-02 |
| Normal-vs-Stage3 |
2.055200E-03 |
| Normal-vs-Stage4 |
1.582980E-04 |
| Stage1-vs-Stage2 |
5.319800E-01 |
| Stage1-vs-Stage3 |
8.815800E-01 |
| Stage1-vs-Stage4 |
3.422600E-01 |
| Stage2-vs-Stage3 |
5.477000E-01 |
| Stage2-vs-Stage4 |
2.464800E-01 |
| Stage3-vs-Stage4 |
5.517200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.8474999963789E-08 |
| Normal-vs-AfricanAmerican |
4.445200E-04 |
| Normal-vs-Asian |
2.374000E-01 |
| Caucasian-vs-AfricanAmerican |
6.295000E-01 |
| Caucasian-vs-Asian |
3.453200E-01 |
| AfricanAmerican-vs-Asian |
3.686600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.179300E-04 |
| Normal-vs-Female |
1.05439990072398E-10 |
| Male-vs-Female |
1.380850E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.092200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.0469000000235E-07 |
| Normal-vs-Age(61-80Yrs) |
1.71479999999669E-06 |
| Normal-vs-Age(81-100Yrs) |
2.663800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.634200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.478200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.341400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.208400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.897800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.034200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.57890000652384E-09 |
| Normal-vs-Grade 2 |
4.47659997959704E-09 |
| Normal-vs-Grade 3 |
9.60719999999471E-05 |
| Normal-vs-Grade 4 |
9.282000E-03 |
| Grade 1-vs-Grade 2 |
3.422200E-02 |
| Grade 1-vs-Grade 3 |
3.783800E-03 |
| Grade 1-vs-Grade 4 |
2.020000E-01 |
| Grade 2-vs-Grade 3 |
1.261390E-01 |
| Grade 2-vs-Grade 4 |
8.852200E-01 |
| Grade 3-vs-Grade 4 |
3.897000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.66005053726349E-13 |
| Normal-vs-ccB subtype |
4.165600E-02 |
| ccA subtype-vs-ccB subtype |
2.156300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.59489999949226E-07 |
| Normal-vs-N1 |
2.414400E-02 |
| N0-vs-N1 |
2.002400E-01 |
|
|
